These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17251563)

  • 41. Variability of the envelope regions of HCV in European isolates and its significance for diagnostic tools.
    Roggendorf M; Lu M; Fuchs K; Ernst G; Höhne M; Schreier E
    Arch Virol Suppl; 1993; 7():27-39. PubMed ID: 8219809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New insight into HCV E1/E2 region of genotype 4a.
    Hussein N; Zekri AR; Abouelhoda M; Alam El-Din HM; Ghamry AA; Amer MA; Sherif GM; Bahnassy AA
    Virol J; 2014 Dec; 11():231. PubMed ID: 25547228
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
    Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
    Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Positive selection analysis of hepatitis C virus genotype 1b envelope 2 gene and its significance during natural chronic infection].
    Zhu Y; Mao Q; Lan L; Hu YJ; Tan ZX; Zhang CJ; Wang YM; Wang XH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jun; 26(6):548-51. PubMed ID: 20487647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Quasispecies sequence analyses of envelope protein E1/E2 coding genes from four Chinese HCV patients and identification of a novel insertion mutation of HCV].
    Li CL; Zhang L; Lu J; Liu XM; Deng Y; Wang Y; Shen XL; Tan WJ
    Bing Du Xue Bao; 2012 Jun; 28(4):336-44. PubMed ID: 22978156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.
    Farci P; Shimoda A; Coiana A; Diaz G; Peddis G; Melpolder JC; Strazzera A; Chien DY; Munoz SJ; Balestrieri A; Purcell RH; Alter HJ
    Science; 2000 Apr; 288(5464):339-44. PubMed ID: 10764648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity.
    Prentoe J; Velázquez-Moctezuma R; Foung SK; Law M; Bukh J
    Hepatology; 2016 Dec; 64(6):1881-1892. PubMed ID: 27351277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
    McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
    Zibert A; Schreier E; Roggendorf M
    Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.
    Douam F; Dao Thi VL; Maurin G; Fresquet J; Mompelat D; Zeisel MB; Baumert TF; Cosset FL; Lavillette D
    Hepatology; 2014 Mar; 59(3):776-88. PubMed ID: 24038151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.
    Liu L; Fisher BE; Dowd KA; Astemborski J; Cox AL; Ray SC
    J Virol; 2010 May; 84(10):5067-77. PubMed ID: 20200239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Humoral immune system targets clonotypic antibody-associated hepatitis C virus.
    Naik AS; Palmer BA; Crosbie O; Kenny-Walsh E; Fanning LJ
    J Gen Virol; 2017 Feb; 98(2):179-189. PubMed ID: 28284234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the PKR-eIF2alpha phosphorylation homology domain (PePHD) of hepatitis C virus genotype 1 in HIV-coinfected patients by ultra-deep pyrosequencing and its relationship to responses to pegylated interferon-ribavirin treatment.
    Bolcic F; Sede M; Moretti F; Westergaard G; Vazquez M; Laufer N; Quarleri J
    Arch Virol; 2012 Apr; 157(4):703-11. PubMed ID: 22270759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy.
    Pawlotsky JM; Germanidis G; Frainais PO; Bouvier M; Soulier A; Pellerin M; Dhumeaux D
    J Virol; 1999 Aug; 73(8):6490-9. PubMed ID: 10400744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Indian sub-continent as hotspot for HCV genotype 3a origin by Bayesian evolutionary reconstruction.
    Choudhary MC; Natarajan V; Pandey P; Gupta E; Sharma S; Tripathi R; Kumar MS; Kazim SN; Sarin SK
    Infect Genet Evol; 2014 Dec; 28():87-94. PubMed ID: 25224661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
    Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
    J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.
    Hamed MR; Tarr AW; McClure CP; Ball JK; Hickling TP; Irving WL
    J Viral Hepat; 2008 May; 15(5):339-45. PubMed ID: 18221305
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.
    Blackard JT; Ma G; Welge JA; Martin CM; Sherman KE; Taylor LE; Mayer KH; Jamieson DJ
    J Med Virol; 2012 Feb; 84(2):242-52. PubMed ID: 22170544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity.
    Curran R; Jameson CL; Craggs JK; Grabowska AM; Thomson BJ; Robins A; Irving WL; Ball JK
    J Gen Virol; 2002 Jan; 83(Pt 1):11-23. PubMed ID: 11752696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus.
    Cao L; Yu B; Kong D; Cong Q; Yu T; Chen Z; Hu Z; Chang H; Zhong J; Baker D; He Y
    PLoS Pathog; 2019 May; 15(5):e1007759. PubMed ID: 31116791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.